Respiratory Infections News

Emerging research has shown that COVID-19 “long-haulers” can face a substantial burden of health loss.

Researchers in San Francisco found that people with HIV had fewer SARS-CoV-2 infections but experienced more cases of severe COVID-19 than people without HIV.

A study of more than 2,600 U.S. adults found “generally low rates” of COVID-19 testing among participants reporting onset of febrile illness through late October 2020, according to results published in JAMA Network Open.

Pfizer and BioNTech have started the process of seeking full FDA approval for their COVID-19 vaccine for use in people aged 16 years or older in the United States.

Moderna said that a single booster dose of its original COVID-19 vaccine — or a modified version made specifically for the variant first identified in South Africa — offered protection against two SARS-CoV-2 variants of concern.

The Biden administration said it will back an effort to waive intellectual property protections for COVID-19 vaccines that has been proposed as a way to make the vaccines more available and affordable for developing countries.

Pfizer expects to be able to submit its COVID-19 vaccine to the FDA for emergency use authorization in children as young as age 2 years in September, Chairman and CEO Albert Bourla, DVM, PhD, said Tuesday.

The effectiveness of the COVID-19 messenger RNA vaccines exceeded 96% among a cohort of more than 49,000 health care workers, according to a study published in Clinical Infectious Diseases.

SARS-CoV-2 reinfection was uncommon and milder than primary infection but was associated with two deaths, according to findings from a U.S. study published in Clinical Infectious Diseases.

President Joe Biden announced Tuesday a new goal to get at least 70% of Americans adults partially vaccinated against COVID-19 by July 4.